Clinical Trial Update: TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of TR115 is currently recruiting in patients with relapsed/refractory non-Hodgkin's lymphoma and advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• TR115

Snippet

Sponsor: Tarapeutics Science Inc. | Conditions: Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory | Phase 1 | Status: RECRUITING